Valcyte

Rediff.com » News » Valcyte

News for Valcyte

Business

Why Sun Pharma stock will remain under pressure

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......

Markets end in green amid volatile trade

The S&P BSE Sensex ended up 45 points at 25330 and the Nifty50 closed 11 points higher at 7,715. In the broader markets, the BSE Midcap and Smallcap indices ended up 0.3%-0.5% each. “Recently......

Pharma in 2014: Deals worth billions and fines worth millions

Even as private firms were busy stitching merger and partnership deals, the government also remained active during the year working on a separate policy to promote and strengthen domestic......

Sensex logs biggest single-day drop this year; sheds 538 points

The 30-share Sensex ended down 538 points at 26,781 and 50-share Nifty ended down 152 points at 8,067. BBenchmark share indices ended at seven-week lows after sharp decline in the rupee,......

Ranbaxy brand may fade away as Sun takes charge

The Ranbaxy brand might be gradually phased out in the near future in the wake of this year’s largest merger in the Asian pharma sector. After Monday’s conditional nod from the......

Rediff News

Valcyte

News for Valcyte

Why Sun Pharma stock will remain under pressure

Markets end in green amid volatile trade

Pharma in 2014: Deals worth billions and fines worth millions

Sensex logs biggest single-day drop this year; sheds 538 points

Ranbaxy brand may fade away as Sun takes charge

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS